Dual-targeted CAR T-cell Therapy Shows Promising Anti-tumor Response in Mice – Myeloma Research News
Myeloma Research News |
Dual-targeted CAR T-cell Therapy Shows Promising Anti-tumor Response in Mice
Myeloma Research News CAR–T cell therapies are based on the genetic manipulation of a patient's own T-cells. This reprogramming is designed to make the T-cells specific to certain cancer proteins, making them more efficient at eliminating tumors. For multiple myeloma … |
